Daily Bulletin

Men's Weekly

.

Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
  • Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders
  • Funds raised will underpin Servatus' live microbial and engineered protein biotherapeutics drug development
  • Two Phase 1/2 clinical trials to launch shortly in Queensland, for insomnia and rheumatoid arthritis, complementing...

Read more: Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics...

Business News

Workplace Health Checks: A Smart Investment for Small Business Success

Running a small business means every team member counts and when poor health leads to absenteeism or low energy, productivity and profits take a hit. Lost workdays, rising healthcare costs, and staff ...

Daily Bulletin - avatar Daily Bulletin

Rising Demand: Why Melbourne Needs More Electricians Now

Melbourne is running on change. Rooftops are filling with solar, carports are getting charge points, and older switchboards are being rebuilt so homes and shops can carry smarter, heavier loads. If yo...

Daily Bulletin - avatar Daily Bulletin

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals